Isolation Technology News

Articles Archive

May 24, 2007: Preventing Exposure to Hazardous Drugs: Engineering-control recommendations in the NIOSH Alert
March 16, 2007: Cleaning Compounding Aseptic Isolators and Class II Biological Safety Cabinets
March 9, 2007: ASHP Urges More Control Over Sterile Compounding
March 1, 2007: A Review of USP's Updates to chapter <797>
February 27, 2007: Effect of Personal Protection Equipment Utilizing Compounding Aseptic Isolators
December 11, 2006: JCHO's Statement
May 18, 2006: USP 797 Revised Regulation-Chemo Compounding
May 12, 2006: USP 797 Revised Regulation-Sterile Compounding
December 20, 2005: Barrier isolators as an alternative to a cleanroom

About the Author

Magdy H. Moussa is President & CEO and founder of Isotech Design, a leader and manufacturer of barrier isolation technology for the biopharmaceuticals, hospitals and pharmacies with references in 14 countries and 5 continents. He holds a B. Com from McGill University and M.B.A. from Concordia University. He has over 20 years experience in the Health Care industry and has worked in senior management positions with reputable companies such as Abbott, Aventis and Adria (Pharmacia-Upjohn). He has affiliations with ISPE, PDA, IACP and CETA.